Status:
UNKNOWN
Cost-Effectiveness of Spyglass Direct Visualization System Facilitated Management for the Patients With Intrahepatic Bile Duct Stone and/or Large Extrahepatic Bile Duct Stone
Lead Sponsor:
Yonsei University
Conditions:
Patients With Large or Impacted Intra- or Extra-hepatic Bile Duct Stone
Eligibility:
All Genders
19-100 years
Phase:
NA
Brief Summary
Endoscopic retrograde cholangio-pancreatectomy (ERCP) is the most commonly used endoscopic method for the treatment of biliary diseases including choledocholithiasis. When the ERCP cannot be performed...
Eligibility Criteria
Inclusion
- IHD stones disease that cannot be treated with the ERCP.
- Huge EHD stone disease that required mechanical/electrohydraulic lithotripsy, according to investigator's clinical decision.
Exclusion
- Patients who disagree with the study
- Patients who underwent total gastrectomy
- Patients with IHD stones located in a peripheral IHD where spyglass cannot reach
Key Trial Info
Start Date :
December 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04743089
Start Date
December 11 2020
End Date
January 1 2023
Last Update
February 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei University College of Medicine
Seoul, South Korea